Logo image of CBZ

CBIZ INC (CBZ) Stock Fundamental Analysis

USA - NYSE:CBZ - US1248051021 - Common Stock

53.81 USD
+1.22 (+2.32%)
Last: 9/29/2025, 8:04:00 PM
53.81 USD
0 (0%)
After Hours: 9/29/2025, 8:04:00 PM
Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to CBZ. CBZ was compared to 82 industry peers in the Professional Services industry. CBZ has a medium profitability rating, but doesn't score so well on its financial health evaluation. CBZ is not overvalued while it is showing excellent growth. This is an interesting combination.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

CBZ had positive earnings in the past year.
In the past year CBZ had a positive cash flow from operations.
In the past 5 years CBZ has always been profitable.
Each year in the past 5 years CBZ had a positive operating cash flow.
CBZ Yearly Net Income VS EBIT VS OCF VS FCFCBZ Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

1.2 Ratios

CBZ's Return On Assets of 2.40% is in line compared to the rest of the industry. CBZ outperforms 48.78% of its industry peers.
The Return On Equity of CBZ (5.77%) is comparable to the rest of the industry.
CBZ has a Return On Invested Capital (4.75%) which is comparable to the rest of the industry.
Measured over the past 3 years, the Average Return On Invested Capital for CBZ is significantly below the industry average of 12.76%.
Industry RankSector Rank
ROA 2.4%
ROE 5.77%
ROIC 4.75%
ROA(3y)4.15%
ROA(5y)4.39%
ROE(3y)10.79%
ROE(5y)10.71%
ROIC(3y)6.53%
ROIC(5y)6.32%
CBZ Yearly ROA, ROE, ROICCBZ Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

With a Profit Margin value of 4.51%, CBZ perfoms like the industry average, outperforming 58.54% of the companies in the same industry.
In the last couple of years the Profit Margin of CBZ has declined.
The Operating Margin of CBZ (10.75%) is better than 73.17% of its industry peers.
CBZ's Operating Margin has declined in the last couple of years.
With a Gross Margin value of 13.70%, CBZ is not doing good in the industry: 81.71% of the companies in the same industry are doing better.
CBZ's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 10.75%
PM (TTM) 4.51%
GM 13.7%
OM growth 3Y-10.26%
OM growth 5Y-4.48%
PM growth 3Y-29.35%
PM growth 5Y-21.21%
GM growth 3Y-10.5%
GM growth 5Y-4.73%
CBZ Yearly Profit, Operating, Gross MarginsCBZ Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CBZ is destroying value.
Compared to 1 year ago, CBZ has more shares outstanding
The number of shares outstanding for CBZ has been reduced compared to 5 years ago.
Compared to 1 year ago, CBZ has a worse debt to assets ratio.
CBZ Yearly Shares OutstandingCBZ Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
CBZ Yearly Total Debt VS Total AssetsCBZ Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

Based on the Altman-Z score of 1.79, we must say that CBZ is in the distress zone and has some risk of bankruptcy.
CBZ's Altman-Z score of 1.79 is on the low side compared to the rest of the industry. CBZ is outperformed by 68.29% of its industry peers.
The Debt to FCF ratio of CBZ is 14.94, which is on the high side as it means it would take CBZ, 14.94 years of fcf income to pay off all of its debts.
CBZ has a Debt to FCF ratio of 14.94. This is in the lower half of the industry: CBZ underperforms 64.63% of its industry peers.
A Debt/Equity ratio of 0.79 indicates that CBZ is somewhat dependend on debt financing.
The Debt to Equity ratio of CBZ (0.79) is worse than 62.20% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.79
Debt/FCF 14.94
Altman-Z 1.79
ROIC/WACC0.65
WACC7.3%
CBZ Yearly LT Debt VS Equity VS FCFCBZ Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.3 Liquidity

A Current Ratio of 1.60 indicates that CBZ should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.60, CBZ is in the better half of the industry, outperforming 60.98% of the companies in the same industry.
A Quick Ratio of 1.60 indicates that CBZ should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.60, CBZ is in the better half of the industry, outperforming 63.41% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.6
Quick Ratio 1.6
CBZ Yearly Current Assets VS Current LiabilitesCBZ Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

9

3. Growth

3.1 Past

CBZ shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 59.02%, which is quite impressive.
The Earnings Per Share has been growing by 16.02% on average over the past years. This is quite good.
The Revenue has grown by 46.49% in the past year. This is a very strong growth!
Measured over the past years, CBZ shows a quite strong growth in Revenue. The Revenue has been growing by 13.84% on average per year.
EPS 1Y (TTM)59.02%
EPS 3Y17.64%
EPS 5Y16.02%
EPS Q2Q%90%
Revenue 1Y (TTM)46.49%
Revenue growth 3Y17.96%
Revenue growth 5Y13.84%
Sales Q2Q%62.73%

3.2 Future

CBZ is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 19.84% yearly.
The Revenue is expected to grow by 20.36% on average over the next years. This is a very strong growth
EPS Next Y36.56%
EPS Next 2Y23.47%
EPS Next 3Y19.84%
EPS Next 5YN/A
Revenue Next Year60.21%
Revenue Next 2Y30.02%
Revenue Next 3Y20.36%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CBZ Yearly Revenue VS EstimatesCBZ Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B
CBZ Yearly EPS VS EstimatesCBZ Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3 4

5

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 13.87, CBZ is valued correctly.
Compared to the rest of the industry, the Price/Earnings ratio of CBZ indicates a rather cheap valuation: CBZ is cheaper than 80.49% of the companies listed in the same industry.
CBZ is valuated rather cheaply when we compare the Price/Earnings ratio to 27.67, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 13.22, which indicates a correct valuation of CBZ.
Based on the Price/Forward Earnings ratio, CBZ is valued a bit cheaper than the industry average as 76.83% of the companies are valued more expensively.
When comparing the Price/Forward Earnings ratio of CBZ to the average of the S&P500 Index (23.13), we can say CBZ is valued slightly cheaper.
Industry RankSector Rank
PE 13.87
Fwd PE 13.22
CBZ Price Earnings VS Forward Price EarningsCBZ Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

CBZ's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. CBZ is cheaper than 65.85% of the companies in the same industry.
The rest of the industry has a similar Price/Free Cash Flow ratio as CBZ.
Industry RankSector Rank
P/FCF 27.65
EV/EBITDA 12.88
CBZ Per share dataCBZ EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as CBZ's earnings are expected to grow with 19.84% in the coming years.
PEG (NY)0.38
PEG (5Y)0.87
EPS Next 2Y23.47%
EPS Next 3Y19.84%

0

5. Dividend

5.1 Amount

No dividends for CBZ!.
Industry RankSector Rank
Dividend Yield N/A

CBIZ INC

NYSE:CBZ (9/29/2025, 8:04:00 PM)

After market: 53.81 0 (0%)

53.81

+1.22 (+2.32%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryProfessional Services
Earnings (Last)07-30 2025-07-30/amc
Earnings (Next)10-23 2025-10-23/bmo
Inst Owners95.18%
Inst Owner Change6.66%
Ins Owners3.48%
Ins Owner Change0.98%
Market Cap2.90B
Analysts85.71
Price Target96.9 (80.08%)
Short Float %7.35%
Short Ratio5.66
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)9.58%
Min EPS beat(2)7.63%
Max EPS beat(2)11.53%
EPS beat(4)4
Avg EPS beat(4)11.64%
Min EPS beat(4)7.63%
Max EPS beat(4)17.49%
EPS beat(8)7
Avg EPS beat(8)4.49%
EPS beat(12)9
Avg EPS beat(12)3.06%
EPS beat(16)12
Avg EPS beat(16)0.6%
Revenue beat(2)0
Avg Revenue beat(2)-3.54%
Min Revenue beat(2)-3.55%
Max Revenue beat(2)-3.52%
Revenue beat(4)1
Avg Revenue beat(4)0.85%
Min Revenue beat(4)-3.55%
Max Revenue beat(4)12.08%
Revenue beat(8)3
Avg Revenue beat(8)1.14%
Revenue beat(12)7
Avg Revenue beat(12)2.19%
Revenue beat(16)11
Avg Revenue beat(16)3.24%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)-1.82%
EPS NQ rev (3m)0%
EPS NY rev (1m)-0.09%
EPS NY rev (3m)0.93%
Revenue NQ rev (1m)-0.25%
Revenue NQ rev (3m)-1.28%
Revenue NY rev (1m)-0.35%
Revenue NY rev (3m)-1.04%
Valuation
Industry RankSector Rank
PE 13.87
Fwd PE 13.22
P/S 1.2
P/FCF 27.65
P/OCF 23.4
P/B 1.54
P/tB N/A
EV/EBITDA 12.88
EPS(TTM)3.88
EY7.21%
EPS(NY)4.07
Fwd EY7.56%
FCF(TTM)1.95
FCFY3.62%
OCF(TTM)2.3
OCFY4.27%
SpS44.84
BVpS35.05
TBVpS-18.68
PEG (NY)0.38
PEG (5Y)0.87
Profitability
Industry RankSector Rank
ROA 2.4%
ROE 5.77%
ROCE 6.61%
ROIC 4.75%
ROICexc 4.8%
ROICexgc 18.78%
OM 10.75%
PM (TTM) 4.51%
GM 13.7%
FCFM 4.34%
ROA(3y)4.15%
ROA(5y)4.39%
ROE(3y)10.79%
ROE(5y)10.71%
ROIC(3y)6.53%
ROIC(5y)6.32%
ROICexc(3y)6.56%
ROICexc(5y)6.34%
ROICexgc(3y)21.85%
ROICexgc(5y)20.77%
ROCE(3y)9.09%
ROCE(5y)8.79%
ROICexcg growth 3Y-18.93%
ROICexcg growth 5Y-6.45%
ROICexc growth 3Y-27.55%
ROICexc growth 5Y-15.96%
OM growth 3Y-10.26%
OM growth 5Y-4.48%
PM growth 3Y-29.35%
PM growth 5Y-21.21%
GM growth 3Y-10.5%
GM growth 5Y-4.73%
F-Score5
Asset Turnover0.53
Health
Industry RankSector Rank
Debt/Equity 0.79
Debt/FCF 14.94
Debt/EBITDA 4.43
Cap/Depr 24.16%
Cap/Sales 0.79%
Interest Coverage 250
Cash Conversion 36.6%
Profit Quality 96.32%
Current Ratio 1.6
Quick Ratio 1.6
Altman-Z 1.79
F-Score5
WACC7.3%
ROIC/WACC0.65
Cap/Depr(3y)38.86%
Cap/Depr(5y)40%
Cap/Sales(3y)0.92%
Cap/Sales(5y)0.96%
Profit Quality(3y)163.09%
Profit Quality(5y)166.86%
High Growth Momentum
Growth
EPS 1Y (TTM)59.02%
EPS 3Y17.64%
EPS 5Y16.02%
EPS Q2Q%90%
EPS Next Y36.56%
EPS Next 2Y23.47%
EPS Next 3Y19.84%
EPS Next 5YN/A
Revenue 1Y (TTM)46.49%
Revenue growth 3Y17.96%
Revenue growth 5Y13.84%
Sales Q2Q%62.73%
Revenue Next Year60.21%
Revenue Next 2Y30.02%
Revenue Next 3Y20.36%
Revenue Next 5YN/A
EBIT growth 1Y61.52%
EBIT growth 3Y5.86%
EBIT growth 5Y8.74%
EBIT Next Year156.31%
EBIT Next 3Y41.05%
EBIT Next 5YN/A
FCF growth 1Y-5.03%
FCF growth 3Y-3.22%
FCF growth 5Y5.61%
OCF growth 1Y-2.53%
OCF growth 3Y-1.95%
OCF growth 5Y4.72%